Magellan Health Inc (MGLN) General Counsel Sells $737,137.00 in Stock

Magellan Health Inc (NASDAQ:MGLN) General Counsel Daniel N. Gregoire sold 8,275 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $89.08, for a total transaction of $737,137.00. Following the transaction, the general counsel now directly owns 16,690 shares of the company’s stock, valued at approximately $1,486,745.20. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Shares of Magellan Health Inc (MGLN) opened at $96.40 on Thursday. The stock has a market cap of $2,300.85, a P/E ratio of 21.80, a P/E/G ratio of 1.23 and a beta of 0.54. Magellan Health Inc has a 1 year low of $64.05 and a 1 year high of $96.85. The company has a current ratio of 2.28, a quick ratio of 2.21 and a debt-to-equity ratio of 0.62.

Magellan Health (NASDAQ:MGLN) last posted its earnings results on Wednesday, November 1st. The company reported $1.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.40 by $0.24. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.49 billion. Magellan Health had a net margin of 1.68% and a return on equity of 9.20%. The company’s revenue was up 9.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.39 EPS. analysts expect that Magellan Health Inc will post 5.19 earnings per share for the current year.

A number of research firms have recently commented on MGLN. KeyCorp reaffirmed a “buy” rating and set a $89.00 price objective on shares of Magellan Health in a research note on Friday, September 22nd. ValuEngine raised shares of Magellan Health from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Zacks Investment Research downgraded shares of Magellan Health from a “buy” rating to a “hold” rating in a research report on Wednesday, October 4th. Raymond James Financial reissued a “hold” rating on shares of Magellan Health in a research report on Saturday, December 2nd. Finally, Jefferies Group reissued a “buy” rating and set a $94.00 target price on shares of Magellan Health in a research report on Friday, October 13th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $90.50.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MGLN. Aperio Group LLC boosted its holdings in Magellan Health by 14.4% in the 2nd quarter. Aperio Group LLC now owns 12,901 shares of the company’s stock worth $940,000 after acquiring an additional 1,627 shares during the period. Municipal Employees Retirement System of Michigan boosted its holdings in Magellan Health by 20.7% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 17,510 shares of the company’s stock worth $1,276,000 after acquiring an additional 3,000 shares during the period. Great West Life Assurance Co. Can boosted its holdings in Magellan Health by 3.4% in the 2nd quarter. Great West Life Assurance Co. Can now owns 33,815 shares of the company’s stock worth $2,463,000 after acquiring an additional 1,100 shares during the period. Texas Permanent School Fund boosted its holdings in Magellan Health by 1.3% in the 2nd quarter. Texas Permanent School Fund now owns 17,316 shares of the company’s stock worth $1,262,000 after acquiring an additional 230 shares during the period. Finally, Arizona State Retirement System boosted its holdings in Magellan Health by 0.8% in the 2nd quarter. Arizona State Retirement System now owns 12,412 shares of the company’s stock worth $905,000 after acquiring an additional 100 shares during the period. Hedge funds and other institutional investors own 94.96% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Magellan Health Inc (MGLN) General Counsel Sells $737,137.00 in Stock” was published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/12/07/magellan-health-inc-mgln-general-counsel-sells-737137-00-in-stock.html.

Magellan Health Company Profile

Magellan Health, Inc is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC).

Insider Buying and Selling by Quarter for Magellan Health (NASDAQ:MGLN)

What are top analysts saying about Magellan Health Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Magellan Health Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit